Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Reactive Arthritis: Chronic or Self-Limiting?

Michael J. Cammarata, MD  |  Issue: June 2025  |  June 8, 2025

In keeping with the features of the spondyloarthopathies, reactive arthritis classically presents with an oligoarthritis, favoring the large joints of the lower extremities. However, polyarticular and small joint involvement is also possible. Dactylitis can be seen in up to 40% of patients, and enthesitis is common at the plantar fascia and Achilles tendon.17 Axial involvement is more common in patients who are HLA-B27 positive.11 Importantly, unilateral axial involvement without peripheral arthritis is highly atypical and suggestive of infection.18

Figure 2. Numerous pustules are present on the feet of a patient with reactive arthritis. They begin as vesicles on erythematous bases and become sterile pustules. On the patient’s right sole, the development of keratotic scales (keratoderma blennorrhagica) is most evident. (Click to enlarge.)

Mucocutaneous manifestations are seen in up to 40% of patients.11 Two characteristic manifestations include keratoderma blenorrhagicum and circinate balanitis. The former is characterized by a hyperkeratotic, psoriasiform rash on the palms and soles (see Figure 2), and the latter features shallow, painless serpinginous ulcerations on the glans penis. Dysuria and penile discharge may also be present. Less specific cutaneous signs include aphthous ulcers and erythema nodusum, both of which can also be seen in inflammatory bowel disease (IBD).

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Ocular manifestations include a sterile conjunctivitis in up to 50–75% of patients, as well as anterior uveitis/iritis in 12% of patients.11 Much like in axial spondyloarthritis, uveitis can be a chronic, recurring manifestation warranting long-term immunosuppression.

Cardiac manifestations are less common, and seen in up to 10% of patients. Manifestations include aortitis and aortic insufficiency, conduction abnormalities and pericarditis, particularly in patients with a longer duration of illness.11

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

There are no specific laboratory tests to confirm the diagnosis. Inflammatory markers, such as erythrocyte sedimentation rate (ESR) and C-reactive protein, are typically elevated, with thrombocytosis and anemia of chronic disease reflecting unchecked inflammation. Exclusion of other rheumatic and infectious diseases is paramount. Gonococcal arthritis, rheumatoid arthritis, spondyloarthropathies (e.g., IBD-associated arthritis and psoriatic arthritis), Lyme disease, viral arthritides, Behçet’s disease and crystalline arthropathies should all be investigated, depending on the patient’s age, history and additional clinical features.

Prognosis

Reactive arthritis is often self-limited, with a good prognosis, resolving over an average of three to five months. About one-third of patients recover fully; however, up to half of patients progress to chronic arthritis.19 Overall, the prognosis of an enteric-induced reactive arthritis seems more favorable than one secondary to infection with Chlamydia.11

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:Axial SpondyloarthritisConditions Tagged with:biologic DMARDsdisease managementextra-articular manifestationsGlucocorticoidsHLA-B27infectious etiologymusculoskeletal manifestationsNSAIDsReactive arthritisspondyloarthritissulfasalazine

Related Articles

    Top Research in Axial Spondyloarthritis Presented at ACR Convergence 2022

    November 18, 2022

    PHILADELPHIA—Approximately 100 research abstracts on axial spondyloarthritis (axSpA) were accepted for presentation at ACR Convergence 2022. It is exciting to see a wealth of research on axSpA being undertaken worldwide. Here, we highlight important points from 10 of these studies. 1. Abstract 0378: Prevalence of Axial Spondyloarthritis (axSpA) in Patients Treated for Chronic Back Pain…

    Rheumatologists Make Progress Defining Spectrum of Axial Spondyloarthritis

    May 1, 2014

    New research clarifies terminology used for diagnosis, but questions remain around epidemiology, genetics and management of patients with axial skeletal inflammation

    Nelosa/shutterstock.com

    Men, Women & Medical Differences in Axial Spondyloarthropathy

    October 24, 2019

    Historically, ankylosing spondylitis was considered mainly a male disease. But it has become evident this predominance is not as great as previously believed. Here we discuss recent developments in the area, including potential differences between the sexes in symptom and disease burden, immunological and genetic background, diagnostic delay, treatment response and ongoing research questions. Medical…

    Key Research in Axial Spondyloarthritis Encapsulated

    December 2, 2024

    Our understanding of (axSpA) has really changed, especially with regard to male-female differences. In this report, we identify important research on axSpA presented at ACR Convergence 2024, summarize the abstracts and comment on why each is important, addressing the relevance for clinicians and the potential impact on future research.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences